ストックスクリーナーアプリを入手
0.00
100.00%
-0.6063
前日終値:
$0.6063
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$82.91M
収益：
$247.99M
当期純損益:
$-521.97M
株価収益率:
0.00
EPS:
-1.11
ネットキャッシュフロー:
$-194.28M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$7.88
23 Andme Holding Co Stock (ME) Company Profile
ME を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
466.76 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
196.75 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
675.52 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.52 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.55 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-29 | 開始されました | Berenberg | Buy |
| 2022-09-22 | 開始されました | Cowen | Outperform |
| 2021-11-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 開始されました | Credit Suisse | Outperform |
| 2021-07-12 | 開始されました | Citigroup | Buy |
23 Andme Holding Co (ME) 最新ニュース
Judge OKs sale of 23andMe in bankruptcy case - MSN
WilmerHale Can Advise 23andMe Ch. 11 Data Ombudsman - Law360
23andMe Ombudsman Beats DOJ Pushback in Bid to Hire WilmerHale - Bloomberg Law News
House Bill Would Close Privacy Loophole Exposed by 23andMe Bankruptcy (Jul 18, 2025) - VitalLaw.com
23andMe Bankruptcy Update: How the Proceedings Highlight Best Practices for Handling and Transferring Genetic Data and Personal Information - Foley Hoag
23andMe data breach class action settlement - Class Action Lawsuits
Lam Research Corporation shares rise 1.72% premarket after TTAM Research Institute completed acquisition of 23andMe Holding Co. - AInvest
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid - MSN
23andMe Holding says debtors repay all outstanding indebtedness, terminate loan agreement - MarketScreener
23andMe Completes Asset Sale Amid Bankruptcy - TipRanks
Press Release: TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - 富途牛牛
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets - The Manila Times
23andMe Founder Saves DNA Testing Service: Nonprofit TTAM Takes Over Customer Data and Research - Stock Titan
23andMe sale approved by judge in bankruptcy case - MSN
23andMe Sale to Proceed as California Continues Appeal (Correct) - Bloomberg Law News
WilmerHale, US Trustee Spar Over Work In 23andMe Ch. 11 - Law360
US judge won't block 23andMe bankruptcy sale to co-founder - Reuters
Judge briefly pauses 23andMe bankruptcy sale amid California's appeal - Reuters
23andMe Privacy Reviewer Defends WilmerHale as Choice of Counsel - Bloomberg Law News
Calif. Fails To Pause 23andMe's Sale During Appeal - Law360
California fails to stop 23andMe founder from re-acquiring company - Reuters
Court quashes appeal relating to 23andMe’s insolvency after global data breach - Law360 Canada
California Appeals 23andMe Genetic Data Sale in Bankruptcy Case - Bloomberg Law News
The Former CEO of 23andMe Bought the Company Back, and I'm Tentatively Optimistic - Lifehacker
Judge approves 23andMe sale - The San Joaquin Valley Sun
Judge approves sale of genetics company 23andMe to founder’s nonprofit group - Washington Times
Judge OKs 23AndMe's $305M Genetic Data Asset Sale - Law360
23andMe wins court OK for $305M asset sale; equity risk flagged | ME SEC FilingForm 8-K - Stock Titan
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation - GlobeNewswire
23andMe's Massive $305M Transformation: Founder Returns to Lead New Nonprofit Future - Stock Titan
23 Andme Holding Co (ME) 財務データ
収益
当期純利益
現金流量
EPS
1.34%
1.09%
大文字化:
|
ボリューム (24 時間):